Market Cap 1.21B
Revenue (ttm) 731.97M
Net Income (ttm) 159.52M
EPS (ttm) N/A
PE Ratio 8.11
Forward PE 9.08
Profit Margin 21.79%
Debt to Equity Ratio 0.80
Volume 656,400
Avg Vol 610,218
Day's Range N/A - N/A
Shares Out 47.14M
Stochastic %K 71%
Beta 0.78
Analysts Sell
Price Target $32.40

Latest News on AMPH

Amphastar Pharmaceuticals: Navigating Through An Inflection Year

May 11, 2025, 11:32 AM EDT - 22 days ago

Amphastar Pharmaceuticals: Navigating Through An Inflection Year


Top 2 Health Care Stocks That May Rocket Higher This Month

Feb 21, 2025, 2:17 PM EST - 3 months ago

Top 2 Health Care Stocks That May Rocket Higher This Month

WST


Amphastar Pharmaceuticals: A Gradual Strategy

Feb 19, 2025, 1:09 PM EST - 3 months ago

Amphastar Pharmaceuticals: A Gradual Strategy


Amphastar Pharmaceuticals: Cheap With Caveats

Jan 3, 2025, 12:48 PM EST - 5 months ago

Amphastar Pharmaceuticals: Cheap With Caveats


Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2

Oct 2, 2024, 12:08 PM EDT - 8 months ago

Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2


6 Beaten Down Stocks Rated Buy (SA Quant)

Aug 19, 2024, 5:00 AM EDT - 10 months ago

6 Beaten Down Stocks Rated Buy (SA Quant)

CAAP CCL STRL TCOM TWLO


Amphastar Pharmaceuticals: Buy When Fear Is Overblown

May 30, 2024, 2:06 AM EDT - 1 year ago

Amphastar Pharmaceuticals: Buy When Fear Is Overblown